• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens?膀胱癌组织学亚型:哪些参数可预测膀胱肿瘤经尿道切除术与根治性膀胱切除术标本之间的一致性?
Cent European J Urol. 2021;74(3):355-361. doi: 10.5173/ceju.2021.140.R1. Epub 2021 Sep 9.
2
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.经尿道切除术和根治性膀胱切除术标本中膀胱尿路上皮癌罕见变异的一致性及临床意义。
Urology. 2014 Nov;84(5):1141-6. doi: 10.1016/j.urology.2014.06.032. Epub 2014 Sep 18.
3
The Accuracy of Transurethral Bladder Resection in Detecting Bladder Cancer Histological Variants and Their Prognostic Value at Radical Cystectomy.经尿道膀胱切除术在检测膀胱癌组织学亚型及其在根治性膀胱切除术中的预后价值方面的准确性。
J Clin Med. 2022 Jan 22;11(3):550. doi: 10.3390/jcm11030550.
4
The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.膀胱尿路上皮癌患者经尿道膀胱肿瘤切除术及膀胱切除术标本中淋巴管侵犯对患者生存的意义。
BJU Int. 2009 Feb;103(4):475-9. doi: 10.1111/j.1464-410X.2008.08011.x. Epub 2008 Oct 6.
5
Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients.80 岁以上肌层浸润性膀胱癌患者行根治性膀胱切除术或经尿道膀胱肿瘤切除术的临床疗效和生活质量:143 例回顾性分析。
Int Urol Nephrol. 2022 Jan;54(1):71-79. doi: 10.1007/s11255-021-03073-5. Epub 2021 Nov 24.
6
Complete transurethral resection of bladder tumor before radical cystectomy is not a risk factor for organ-confined bladder cancer: A case-control study.根治性膀胱切除术前行膀胱肿瘤完全经尿道切除术并非器官局限性膀胱癌的危险因素:一项病例对照研究。
Curr Urol. 2022 Sep;16(3):142-146. doi: 10.1097/CU9.0000000000000110. Epub 2022 Aug 27.
7
The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy.基于六亚甲基乙二醛的膀胱肿瘤切除术对接受根治性膀胱切除术治疗的原发性非肌肉浸润性膀胱癌患者的预后影响。
World J Urol. 2020 Feb;38(2):397-406. doi: 10.1007/s00345-019-02780-0. Epub 2019 Apr 27.
8
Impact of Lymphovascular Invasion on Prognosis in the Patients with Bladder Cancer-Comparison of Transurethral Resection and Radical Cystectomy.淋巴管浸润对膀胱癌患者预后的影响——经尿道切除术与根治性膀胱切除术的比较
Diagnostics (Basel). 2021 Feb 4;11(2):244. doi: 10.3390/diagnostics11020244.
9
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.光动力诊断辅助经尿道膀胱肿瘤切除术对根治性膀胱切除术后预后结果的影响:来自2011年PROMETRICS研究的结果
World J Urol. 2017 Feb;35(2):245-250. doi: 10.1007/s00345-016-1877-4. Epub 2016 Jun 14.
10
Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.在经尿道膀胱肿瘤切除术再分期时,对于残余 T1 膀胱癌患者,即刻根治性膀胱切除术的作用。
BJU Int. 2013 Jul;112(1):54-9. doi: 10.1111/j.1464-410X.2012.11391.x. Epub 2012 Nov 13.

引用本文的文献

1
Predicting variant histology in bladder cancer: the role of multiparametric MRI and vesical imaging-reporting and data system (VI-RADS).预测膀胱癌的组织学变异:多参数磁共振成像及膀胱影像报告和数据系统(VI-RADS)的作用。
Abdom Radiol (NY). 2025 Mar 18. doi: 10.1007/s00261-025-04852-9.
2
A stacking ensemble system for identifying the presence of histological variants in bladder carcinoma: a multicenter study.一种用于识别膀胱癌组织学变异存在情况的堆叠集成系统:一项多中心研究。
Front Oncol. 2025 Jan 10;14:1469427. doi: 10.3389/fonc.2024.1469427. eCollection 2024.
3
New Challenges in Bladder Cancer Diagnosis: How Biosensing Tools Can Lead to Population Screening Opportunities.膀胱癌诊断中的新挑战:生物传感工具如何带来人群筛查机会。
Sensors (Basel). 2024 Dec 10;24(24):7873. doi: 10.3390/s24247873.
4
Tumor necrosis in magnetic resonance imaging predicts urothelial carcinoma with squamous differentiation in muscle-invasive bladder carcinoma.磁共振成像中的肿瘤坏死可预测肌层浸润性膀胱癌中的具有鳞状分化的尿路上皮癌。
Abdom Radiol (NY). 2024 Dec;49(12):4341-4351. doi: 10.1007/s00261-024-04317-5. Epub 2024 Aug 2.
5
MRI-based automated machine learning model for preoperative identification of variant histology in muscle-invasive bladder carcinoma.基于 MRI 的自动化机器学习模型用于术前识别肌层浸润性膀胱癌的变异组织学。
Eur Radiol. 2024 Mar;34(3):1804-1815. doi: 10.1007/s00330-023-10137-w. Epub 2023 Sep 2.
6
The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers-What Should a Urologist Really Know?新型膀胱癌诊断和监测生物标志物的作用——泌尿科医生应该真正了解哪些内容?
Int J Environ Res Public Health. 2022 Aug 5;19(15):9648. doi: 10.3390/ijerph19159648.
7
Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes?膀胱内治疗非肌肉浸润性膀胱癌:鳞状细胞癌变异对肿瘤学结果的真正影响是什么?
Medicina (Kaunas). 2022 Jan 7;58(1):90. doi: 10.3390/medicina58010090.

本文引用的文献

1
Value of separate tumor base biopsy in transurethral resection of bladder tumors.膀胱肿瘤经尿道切除术中单独肿瘤基底部活检的价值
Cent European J Urol. 2020;73(4):440-444. doi: 10.5173/ceju.2020.0073. Epub 2020 Nov 6.
2
Diagnostic and treatment delays among patients with primary bladder cancer in Poland: a survey study.波兰原发性膀胱癌患者的诊断和治疗延误:一项调查研究。
Cent European J Urol. 2020;73(2):152-159. doi: 10.5173/ceju.2020.0158. Epub 2020 Jun 18.
3
A Systematic Review and Meta-Analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.根治性膀胱切除术治疗的膀胱尿路上皮癌的变异组织学的系统评价和荟萃分析。
J Urol. 2020 Dec;204(6):1129-1140. doi: 10.1097/JU.0000000000001305. Epub 2020 Jul 27.
4
An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting.国际协作共识声明:整块切除膀胱肿瘤,包含两项系统评价、两轮德尔菲调查和一次共识会议。
Eur Urol. 2020 Oct;78(4):546-569. doi: 10.1016/j.eururo.2020.04.059. Epub 2020 May 8.
5
The Learning Curve for Transurethral Resection of Bladder Tumour: How Many is Enough to be Independent, Safe and Effective Surgeon?经尿道膀胱肿瘤切除术的学习曲线:成为一名独立、安全且高效的外科医生需要进行多少例手术?
J Surg Educ. 2020 Jul-Aug;77(4):978-985. doi: 10.1016/j.jsurg.2020.02.010. Epub 2020 Mar 5.
6
Contemporary surgical and technical aspects of transurethral resection of bladder tumor.经尿道膀胱肿瘤切除术的当代外科及技术层面
Transl Androl Urol. 2019 Feb;8(1):21-24. doi: 10.21037/tau.2019.01.04.
7
En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer.整块切除提高非肌层浸润性膀胱癌中黏膜肌层的识别率。
World J Urol. 2019 Dec;37(12):2677-2682. doi: 10.1007/s00345-019-02672-3. Epub 2019 Mar 4.
8
The pathologist's role in the detection of rare variants of bladder cancer and analysis of the impact on incidence and type detection.病理学家在膀胱癌罕见变异的检测以及对发病率和类型检测影响的分析中的作用。
Minerva Urol Nefrol. 2018 Dec;70(6):594-597. doi: 10.23736/S0393-2249.18.03175-2. Epub 2018 Sep 10.
9
Characteristics and clinical significance of histological variants of bladder cancer.膀胱癌的组织学变异特征及临床意义。
Nat Rev Urol. 2017 Nov;14(11):651-668. doi: 10.1038/nrurol.2017.125. Epub 2017 Sep 12.
10
Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study.单纯经尿道切除术是否足以诊断组织学变异型?一项单中心研究。
Urol Oncol. 2017 Aug;35(8):528.e1-528.e5. doi: 10.1016/j.urolonc.2017.03.024. Epub 2017 Apr 19.

膀胱癌组织学亚型:哪些参数可预测膀胱肿瘤经尿道切除术与根治性膀胱切除术标本之间的一致性?

Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens?

作者信息

Mantica Guglielmo, Tappero Stefano, Parodi Stefano, Piol Nataniele, Spina Bruno, Malinaric Rafaela, Balzarini Federica, Borghesi Marco, Van Der Merwe André, Suardi Nazareno, Terrone Carlo

机构信息

Department of Urology, Policlinico San Martino Hospital, University of Genova, Genova, Italy.

Department of Pathology, Policlinico San Martino Hospital, University of Genova, Genova, Italy.

出版信息

Cent European J Urol. 2021;74(3):355-361. doi: 10.5173/ceju.2021.140.R1. Epub 2021 Sep 9.

DOI:10.5173/ceju.2021.140.R1
PMID:34729225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8552936/
Abstract

INTRODUCTION

The concordance rate of bladder cancer (BCa) histological variants (HV) between transurethral resection of bladder tumor (TURBT) and radical cystectomy (RC) is sub-optimal and is unclear which factors may influence it. The aim of this study was to identify factors that may be correlated to a higher TURBT-RC concordance rate.

MATERIAL AND METHODS

Consecutive patients who had undergone RC between 2000 and 2019 at a single Institution with pathological evidence of HV were included. Patients with diagnosis of HV both at RC and at the previous TURBT were enlisted in the TURBT-RC Concordance Group (CG), whereas patients with only evidence of HV at RC in the TURBT-RC Non-Concordance Group (NCG). Surgical factors evaluated were the source of energy (mono- vs bipolar), surgeon's experience (</≥100), execution of re-TURBT, number and size of specimens at TURBT.

RESULTS

A total of 81 patients were included, 49 (60.5%) in the CG and 32 (39.5%) in the NCG. Among the surgical factors, maximal core length (MCL) was significantly higher in the CG (12.5 vs 10 mm, p = 0.014) (Table 1). At uni- and multivariable analyses, MCL>10 mm represented an independent predictor of concordance [OR 2.95; CI (1.01-8.61); p = 0.048]. Tumor recurrence, focality and dimension, source of energy, surgeon's experience, performance of re-TURBT and total number of specimens at TURBT did not significantly predict the concordance.

CONCLUSIONS

Longer specimens at TURBT yield a higher chance to detect HV before RC. In this light, improving the quality of bladder resection means improving the management of BCa.

摘要

引言

经尿道膀胱肿瘤切除术(TURBT)与根治性膀胱切除术(RC)之间膀胱癌(BCa)组织学变体(HV)的一致性率不理想,目前尚不清楚哪些因素可能会影响该一致性率。本研究的目的是确定可能与更高的TURBT-RC一致性率相关的因素。

材料与方法

纳入2000年至2019年期间在单一机构接受RC且有HV病理证据的连续患者。在RC和先前的TURBT中均诊断为HV的患者被纳入TURBT-RC一致性组(CG),而仅在RC时有HV证据的患者被纳入TURBT-RC不一致组(NCG)。评估的手术因素包括能量来源(单极与双极)、外科医生的经验(< /≥100)、再次TURBT的实施情况、TURBT时标本的数量和大小。

结果

共纳入81例患者,CG组49例(60.5%),NCG组32例(39.5%)。在手术因素中,CG组的最大核心长度(MCL)显著更高(12.5对10mm,p = 0.014)(表1)。在单变量和多变量分析中,MCL>10mm是一致性的独立预测因素[OR 2.95;CI(1.01 - 8.61);p = 0.048]。肿瘤复发、局灶性和大小、能量来源、外科医生的经验、再次TURBT的实施情况以及TURBT时标本的总数均未显著预测一致性。

结论

TURBT时获取更长的标本可增加在RC前检测到HV的机会。据此,提高膀胱切除术的质量意味着改善BCa的管理。